Magnesium supplement therapy in type2 diabetes
Phase 3
- Conditions
- Type 2 diabetes.Type 2 diabetes mellitus
- Registration Number
- IRCT20220504054735N1
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
An adult patient with type 2 diabetes who has been diagnosed and treated for at least one year and been treated with oral medications only.
The patient's HbA1c level should be between 7 to 10.
The patient should be satisfied to participate in the study.
Exclusion Criteria
Injecting insulin and taking magnesium and calcium supplements, calcium channel blockers, and diuretics.
Renal failure, elevated liver enzymes, inflammatory disease, chronic diarrhea, and pregnancy.
Participants should not have been admitted to another clinical trial at the same time.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Insulin resistance. Timepoint: Measurement of blood factors will be done twice (one at the beginning, before the start of the intervention, and the other three months later). Method of measurement: Blood tests.
- Secondary Outcome Measures
Name Time Method